Splet15. jul. 2013 · While the TRAIL pathway represents a promising therapeutic target in melanoma, resistance to TRAIL-mediated apoptosis remains a barrier to its successful adoption. Splet10. nov. 2016 · Abstract. It is known that tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) could induce both apoptosis and autophagy. Here, we summarized the recent findings of the key regulators and the crosstalk pathway that highlights the intricate interplay between TRAIL‐induced apoptosis and autophagy.
Death receptor 5 - Wikipedia
SpletThe CASP8 gene encodes a member of the cysteine - aspartic acid protease ( caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive … Splet11. maj 2006 · The proteasome inhibitors are a new class of antitumor agents. These inhibitors cause the accumulation of many proteins in the cell with the induction of apoptosis including TRAIL death receptors DR4 and DR5, but the role of the TRAIL apoptotic pathway in proteasome inhibitor cytotoxicity is unknown. Herein, we have … navy leather counter stool
TRAIL pathway targeting therapeutics - PubMed
Splet12. apr. 2024 · Death receptor ligand TRAIL is a promising cancer therapy due to its ability to selectively trigger extrinsic apoptosis in cancer cells. However, TRAIL–based therapies in humans have shown limitations, mainly due inherent or acquired resistance of tumor cells. To address this issue, current efforts are focussed on dissecting the intracellular … Splet01. jun. 2007 · Although the TRAIL pathway may seem like a rather simple apoptosis signaling pathway (the receptors bind the ligand and then directly activate caspases), it … SpletTRAIL Pathway TRAIL Pathway Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) binds to TRAIL receptor 1 and 2 (TRAILR1/TRAILR2) on the cell surface to … marks and spencer beauty box offer 2020